ProAxsis Evaluates Point-of-Use Test for COPD Exacerbations in New Study
The 21-month clinical research study with Imperial College London will assess the diagnostic value of a lateral flow test for active neutrophil elastase.
Read MorePosted by CLP Edit Staff | Jul 29, 2026 | Flu & Respiratory Infections |
The 21-month clinical research study with Imperial College London will assess the diagnostic value of a lateral flow test for active neutrophil elastase.
Read MorePosted by CLP Edit Staff | Jul 27, 2026 | Mass Spectrometry Instruments |
Waters has introduced the Xevo TQ Absolute XR IVD Mass Spectrometer, featuring up to five times greater sensitivity for clinical applications at the 2026 ADLM Annual Meeting.
Read MorePosted by CLP Edit Staff | Jul 27, 2026 | Infectious Diseases, Molecular Diagnostics, Sexually Transmitted Diseases |
The funding will support regulatory certification and the commercial launch of rapid tests for Lyme disease and sexually transmitted infections.
Read MorePosted by CLP Edit Staff | Jul 24, 2026 | Gastrointestinal Infections, Molecular Diagnostics |
As Cyclospora infections surge in the US, laboratories face increased pressure to quickly differentiate cases, with the CDC reporting 1,947 confirmed infections and 98 hospitalizations across nine states as of July 24.
Read MorePosted by CLP Edit Staff | Jul 24, 2026 | Company News, Infectious Diseases, Lab Automation |
Revvity is developing the T-SPOT A201, an automated platform for latent tuberculosis testing in high-volume labs, with planned launch in 2027 pending regulatory approval.
Read More